This is more pronounced in individuals with conditions like Polycystic Ovary Syndrome (PCOS), where semaglutide might help manage symptoms but also potentially disrupt the menstrual cycle due to its weight loss effects
This means the FDA has not evaluated evidence of the drugs safety as a weight loss medication
On average, people taking semaglutide lost about 15% of their body weight over 68 weeks
Left thigh one week, right thigh the next, is a legitimate rotation
Enhanced Quality of Life: Many individuals report improvements in their overall quality of life, including increased energy levels, better mood, and higher self-esteem
SEE ALSO | FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients To protect yourself, the FDA is urging pharmacies and patients to check their 1 milligram of Ozempic supply to make sure they do not have the counterfeit product and compare the lot and serial numbers with what the FDA is saying are fakes